JENNA LUCZKA: Open Payments
NPI 1972147874 · SMITHFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 110 payments from 22 companies in 2025. Trend: 2023 $2,210 · 2024 $2,558 · 2025 $1,864
Food & beverage: $1,864
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $363 |
| AstraZeneca Pharmaceuticals LP | 5 | $262 |
| PFIZER INC. | 10 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $160 |
| ABBVIE INC. | 14 | $159 |
| Lilly USA, LLC | 10 | $138 |
| GlaxoSmithKline, LLC. | 11 | $138 |
| INTUITIVE SURGICAL, INC. | 1 | $93 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
Products named: FARXIGA, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, QULIPTA, Da Vinci Surgical System, Wegovy, ELIQUIS.
Industry payments across PA — which companies pay providers there.
